After 30 years of speculation about whether the three month shot makes women more likely to contract HIV, we finally have an answer.
The ECHO trial is out: Depo Provera doesn’t lead to HIV
Subscribe to the M&G
These are unprecedented times, and the role of media to tell and record the story of South Africa as it develops is more important than ever.
The Mail & Guardian is a proud news publisher with roots stretching back 35 years, and we’ve survived right from day one thanks to the support of readers who value fiercely independent journalism that is beholden to no-one. To help us continue for another 35 future years with the same proud values, please consider taking out a subscription.
